Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Heart Group is a leading cardiovascular medical practice and clinical research center based in Lancaster, Pennsylvania, and is a key component of the Penn Medicine Lancaster General Health system. The organization provides a full spectrum of cardiac services, including interventional cardiology, electrophysiology, and advanced heart failure management. Beyond its clinical operations, The Heart Group is highly regarded for its robust clinical research program, serving as a primary site for numerous Phase II and III clinical trials sponsored by major pharmaceutical and medical device companies. This integration of community-based care with high-level academic research allows the group to contribute significantly to the development and validation of next-generation cardiovascular therapies. Its affiliation with the University of Pennsylvania Health System further strengthens its position as a regional center for complex cardiac innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Heart Group.